Point/Counterpoint: Arguments for and against Beta-Blocker Use in Hypertension

Caroline Helwick

doi:10.1177/155989770700700719

Caroline Helwick

University of Glasgow School of Medicine, Glasgow, Scotland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
View author's works on this site

Adrian J.B. Brady

University of Glasgow School of Medicine, Glasgow, Scotland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
View author's works on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Summary

This article discusses the use of beta-blockers in the treatment of hypertension. Also discussed are the LIFE, ASCOT-LLA, ASCOT-BPLA, and ASCOT-CAFE trials, as well as European Society of Hypertension/European Society of Cardiology hypertension guidelines.

hypertensive disease

View Full Text

PreviousNext

Tools

Download PDF

View Full Page PDF

Citation Tools

Point/Counterpoint: Arguments for and against Beta-Blocker Use in Hypertension

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Thank you for your interest in spreading the word on MD Conference Express.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Point/Counterpoint: Arguments for and against Beta-Blocker Use in Hypertension

Message Subject (Your Name) has sent you a message from MD Conference Express

Message Body (Your Name) thought you would like to see the MD Conference Express web site.

Your Personal Message